[Form 4] Airsculpt Technologies, Inc. Insider Trading Activity

Rhea-AI Filing Summary

AirSculpt Technologies' Chief Financial Officer received new equity awards tied to service and performance. On January 24, 2026, the CFO was granted 147,059 restricted stock units (RSUs) and 147,059 performance stock units (PSUs) at a price of $0 per unit.

The RSUs vest in three equal annual installments starting January 24, 2027, contingent on continued employment. Each PSU represents a right to one share of common stock and will vest based on relative total shareholder return over a three-year period compared with the S&P Health Care Select Industry Index, with outcomes ranging from 0% to 200% of the target award.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Arthur Michael J

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Performance Stock Units	147,059	$0.00	--
Grant/Award	Common Stock, $0.001 Par Value	147,059	$0.00	--

Holdings After Transaction: Performance Stock Units — 147,059 shares (Direct); Common Stock, $0.001 Par Value — 147,059 shares (Direct)

Footnotes (1)

1. The Reporting Person was granted an award of 147,059 Restricted Stock Units ("RSUs") on January 24, 2026 pursuant to the 2021 Equity Incentive Plan of AirSculpt Technologies, Inc. (the "Company"). Under the terms of the RSU award, the RSUs will vest in three equal annual installments, subject to the Reporting Person's continued employment with the Company, beginning on January 24, 2027. The Reporting Person was granted an award of 147,059 Performance Stock Units ("PSUs") on January 24, 2026 pursuant to the Company's 2021 Equity Incentive Plan. Each PSU represents a contingent right to receive one share of Company common stock. Under the terms of the PSU award, the PSUs will vest subject to a relative total shareholder return performance goal over a three-year performance period relative to the total shareholder return of the S&P Health Care Select Industry Index, with performance ranging from 0% to 200% of the target award, as determined at the end of the three-year performance period.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Arthur Michael J

(Last) (First) (Middle)

C/O AIRSCULPT TECHNOLOGIES, INC.

1111 LINCOLN ROAD, SUITE 802

(Street)

MIAMI BEACH FL 33139

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Airsculpt Technologies, Inc. [ AIRS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/24/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.001 Par Value	01/24/2026		A(1)		147,059	A	$0	147,059	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance Stock Units	(2)	01/24/2026		A		147,059		(2)	01/24/2029	Common Stock	147,059	$0	147,059	D

Explanation of Responses:

1. The Reporting Person was granted an award of 147,059 Restricted Stock Units ("RSUs") on January 24, 2026 pursuant to the 2021 Equity Incentive Plan of AirSculpt Technologies, Inc. (the "Company"). Under the terms of the RSU award, the RSUs will vest in three equal annual installments, subject to the Reporting Person's continued employment with the Company, beginning on January 24, 2027.

2. The Reporting Person was granted an award of 147,059 Performance Stock Units ("PSUs") on January 24, 2026 pursuant to the Company's 2021 Equity Incentive Plan. Each PSU represents a contingent right to receive one share of Company common stock. Under the terms of the PSU award, the PSUs will vest subject to a relative total shareholder return performance goal over a three-year performance period relative to the total shareholder return of the S&P Health Care Select Industry Index, with performance ranging from 0% to 200% of the target award, as determined at the end of the three-year performance period.

	/s/ Thomas P. Conaghan, Attorney-in-Fact	01/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.